Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer

Overview of attention for article published in Clinical Cancer Research, October 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#8 of 17,708)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 53 news outlets
blogs: 4 blogs
twitter: 226 X users

facebook: 5 Facebook pages
wikipedia: 5 Wikipedia pages
reddit: 4 Redditors

Readers on

mendeley: 89 Mendeley

So far, Altmetric has seen 5 citations on 5 Wikipedia pages.

Swedish

Onkolytiskt virus

Cited by user Calandigary Ahmed UU on 12 Feb 2024

Ett onkolytiskt virus är ett virus som företrädesvis infekterar och dödar cancerceller.

Japanese

ICAM-1

Cited by user Smilesworth on 08 May 2021

English

Oncolytic virus

Cited by user Teaktl17 on 06 Jul 2019

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious…

English

ICAM-1

Cited by user Teaktl17 on 06 Jul 2019

ICAM-1 (Intercellular Adhesion Molecule 1) also known as CD54 (Cluster of Differentiation 54) is a protein that in humans is encoded by the ICAM1 gene.

This page shows the most recent Wikipedia articles that mention this research output. Click here to find out how to access more activity, including 1 additional Wikipedia articles.